AFT.nz - AFT Pharmaceuticals Limited | |
---|---|
Overall | |
Targets | Six months: 4.284 One year: 4.579 |
Supports | Support1: 3.260 Support2: 2.712 |
Resistances | Resistance1: 3.668 Resistance2: 3.920 |
Pivot Point | 3.667 |
Moving Averages | MA(5): 3.506 MA(20): 3.691 MA(100): 3.569 MA(250): 3.608 |
MACD | MACD(12,26): -0.01 Signal(12,26,9): 0.03 |
Stochastic Oscillator | %K(14,3): 6.5 %D(3): 4.3 |
RSI | RSI(14): 40.4 |
52-Week | High: 4.080 Low: 3.180 Change(%): -7.7 |
Average Volume(K) | 3-Month: 2968 10-Days: 1042.959961 |
Moving Averages analysis |
---|
Price has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term. |
Bollinger Bands Analysis |
---|
AFT.NZ has closed above bottom band by 18.3%. Bollinger Bands are 53.7% wider than normal. The large width of the bands suggest high volatility as compared to AFT.NZ's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
Stock Technical Analysis Charts |
---|
Financials | |
---|---|
EPS | |
EPS Est. Current Year | |
EPS Est. Next Year | |
EPS Est. Next Quarter | |
Forward EPS | |
Shares Out. (M) | |
Shares Float (M) | |
Book Value (p.s.) | |
PEG Ratio | |
Profit Margin | |
Operating Margin | |
Return on Assets (ttm) | |
Return on Equity (ttm) | |
Qtrly Rev. Growth | |
Gross Profit (p.s.) | |
Sales Per Share | |
EBITDA (p.s.) | |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | |
Levered Free Cash Flow (M) |
Valuation | |
---|---|
P/E | |
P/E Growth Ratio | |
P/BV | |
P/S | |
P/CF |